Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

TRPV1 activation power can switch an action mode for its polypeptide ligands.

Nikolaev MV, Dorofeeva NA, Komarova MS, Korolkova YV, Andreev YA, Mosharova IV, Grishin EV, Tikhonov DB, Kozlov SA.

PLoS One. 2017 May 5;12(5):e0177077. doi: 10.1371/journal.pone.0177077. eCollection 2017.

2.

New Disulfide-Stabilized Fold Provides Sea Anemone Peptide to Exhibit Both Antimicrobial and TRPA1 Potentiating Properties.

Logashina YA, Solstad RG, Mineev KS, Korolkova YV, Mosharova IV, Dyachenko IA, Palikov VA, Palikova YA, Murashev AN, Arseniev AS, Kozlov SA, Stensvåg K, Haug T, Andreev YA.

Toxins (Basel). 2017 Apr 29;9(5). pii: E154. doi: 10.3390/toxins9050154.

3.

New Derivatives of Natural Acyclic Guanidine Alkaloids with TRPV Receptor-Regulating Properties.

Ogurtsova EK, Makarieva TN, Korolkova YV, Andreev YA, Mosharova IV, Denisenko VA, Dmitrenok PS, Lee YJ, Grishin EV, Stonik VA.

Nat Prod Commun. 2015 Jul;10(7):1171-3.

PMID:
26411002
4.

Polypeptide modulators of TRPV1 produce analgesia without hyperthermia.

Andreev YA, Kozlov SA, Korolkova YV, Dyachenko IA, Bondarenko DA, Skobtsov DI, Murashev AN, Kotova PD, Rogachevskaja OA, Kabanova NV, Kolesnikov SS, Grishin EV.

Mar Drugs. 2013 Dec 16;11(12):5100-15. doi: 10.3390/md11125100.

5.

Pulchranins B and C, new acyclic guanidine alkaloids from the Far-Eastern marine sponge Monanchora pulchra.

Makarieva TN, Ogurtsova EK, Korolkova YV, Andreev YA, Mosharova IV, Tabakmakher KM, Guzii AG, Denisenko VA, Dmitrenok PS, Lee HS, Grishin EV, Stonik VA.

Nat Prod Commun. 2013 Sep;8(9):1229-32.

PMID:
24273853
6.

Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.

Kudryashova KS, Nekrasova OV, Kuzmenkov AI, Vassilevski AA, Ignatova AA, Korolkova YV, Grishin EV, Kirpichnikov MP, Feofanov AV.

Anal Bioanal Chem. 2013 Mar;405(7):2379-89. doi: 10.1007/s00216-012-6655-6. Epub 2013 Jan 11.

PMID:
23307127
7.

Modulation of P2X3 receptors by spider toxins.

Kabanova NV, Vassilevski AA, Rogachevskaja OA, Bystrova MF, Korolkova YV, Pluzhnikov KA, Romanov RA, Grishin EV, Kolesnikov SS.

Biochim Biophys Acta. 2012 Nov;1818(11):2868-75. doi: 10.1016/j.bbamem.2012.07.016. Epub 2012 Jul 25.

8.

Novel class of spider toxin: active principle from the yellow sac spider Cheiracanthium punctorium venom is a unique two-domain polypeptide.

Vassilevski AA, Fedorova IM, Maleeva EE, Korolkova YV, Efimova SS, Samsonova OV, Schagina LV, Feofanov AV, Magazanik LG, Grishin EV.

J Biol Chem. 2010 Oct 15;285(42):32293-302. doi: 10.1074/jbc.M110.104265. Epub 2010 Jul 24.

9.

Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain.

Grishin EV, Savchenko GA, Vassilevski AA, Korolkova YV, Boychuk YA, Viatchenko-Karpinski VY, Nadezhdin KD, Arseniev AS, Pluzhnikov KA, Kulyk VB, Voitenko NV, Krishtal OO.

Ann Neurol. 2010 May;67(5):680-3. doi: 10.1002/ana.21949.

PMID:
20437566
10.

Recombinant Kv channels at the membrane of Escherichia coli bind specifically agitoxin2.

Nekrasova OV, Ignatova AA, Nazarova AI, Feofanov AV, Korolkova YV, Boldyreva EF, Tagvei AI, Grishin EV, Arseniev AS, Kirpichnikov MP.

J Neuroimmune Pharmacol. 2009 Mar;4(1):83-91. doi: 10.1007/s11481-008-9116-4. Epub 2008 Jul 23.

PMID:
18649142
11.

Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling.

Tseng GN, Sonawane KD, Korolkova YV, Zhang M, Liu J, Grishin EV, Guy HR.

Biophys J. 2007 May 15;92(10):3524-40. Epub 2007 Feb 9.

12.

KCNE2 is colocalized with KCNQ1 and KCNE1 in cardiac myocytes and may function as a negative modulator of I(Ks) current amplitude in the heart.

Wu DM, Jiang M, Zhang M, Liu XS, Korolkova YV, Tseng GN.

Heart Rhythm. 2006 Dec;3(12):1469-80. Epub 2006 Aug 25.

PMID:
17161791
13.

Species diversity and peptide toxins blocking selectivity of ether-a-go-go-related gene subfamily K+ channels in the central nervous system.

Restano-Cassulini R, Korolkova YV, Diochot S, Gurrola G, Guasti L, Possani LD, Lazdunski M, Grishin EV, Arcangeli A, Wanke E.

Mol Pharmacol. 2006 May;69(5):1673-83. Epub 2006 Feb 23.

PMID:
16497878
14.

Dynamic conformational changes of extracellular S5-P linkers in the hERG channel.

Jiang M, Zhang M, Maslennikov IV, Liu J, Wu DM, Korolkova YV, Arseniev AS, Grishin EV, Tseng GN.

J Physiol. 2005 Nov 15;569(Pt 1):75-89. Epub 2005 Sep 8.

15.

Unique interaction of scorpion toxins with the hERG channel.

Korolkova YV, Tseng GN, Grishin EV.

J Mol Recognit. 2004 May-Jun;17(3):209-17. Review.

PMID:
15137031
16.

A radiolabeled peptide ligand of the hERG channel, [125I]-BeKm-1.

Angelo K, Korolkova YV, Grunnet M, Grishin EV, Pluzhnikov KA, Klaerke DA, Knaus HG, Møller M, Olesen SP.

Pflugers Arch. 2003 Oct;447(1):55-63. Epub 2003 Aug 5.

PMID:
12905030
17.

BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.

Zhang M, Korolkova YV, Liu J, Jiang M, Grishin EV, Tseng GN.

Biophys J. 2003 May;84(5):3022-36.

18.

New binding site on common molecular scaffold provides HERG channel specificity of scorpion toxin BeKm-1.

Korolkova YV, Bocharov EV, Angelo K, Maslennikov IV, Grinenko OV, Lipkin AV, Nosyreva ED, Pluzhnikov KA, Olesen SP, Arseniev AS, Grishin EV.

J Biol Chem. 2002 Nov 8;277(45):43104-9. Epub 2002 Jul 31.

Supplemental Content

Loading ...
Support Center